Adaptive Biotechnologies Corp (ADPT)
4.37
-0.05
(-1.13%)
USD |
NASDAQ |
Nov 21, 16:00
4.45
+0.08
(+1.83%)
After-Hours: 07:53
Adaptive Biotechnologies Total Liabilities (Quarterly): 334.93M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 334.93M |
| June 30, 2024 | 343.44M |
| March 31, 2024 | 345.56M |
| December 31, 2023 | 352.86M |
| September 30, 2023 | 356.04M |
| June 30, 2023 | 368.57M |
| March 31, 2023 | 367.51M |
| December 31, 2022 | 392.52M |
| September 30, 2022 | 396.39M |
| June 30, 2022 | 288.32M |
| March 31, 2022 | 304.94M |
| December 31, 2021 | 319.24M |
| Date | Value |
|---|---|
| September 30, 2021 | 341.06M |
| June 30, 2021 | 340.06M |
| March 31, 2021 | 346.38M |
| December 31, 2020 | 373.15M |
| September 30, 2020 | 320.43M |
| June 30, 2020 | 324.88M |
| March 31, 2020 | 323.32M |
| December 31, 2019 | 341.26M |
| September 30, 2019 | 331.47M |
| June 30, 2019 | 885.77M |
| March 31, 2019 | 326.49M |
| December 31, 2018 | 590.80M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
288.32M
Minimum
Jun 2022
396.39M
Maximum
Sep 2022
344.04M
Average
342.35M
Median
Total Liabilities (Quarterly) Benchmarks
| The Cooper Companies Inc | 4.183B |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 558.51M |
| Shareholders Equity (Quarterly) | 223.77M |
| Current Ratio | 3.519 |